primary ophthalmic solutions

Live YoungSmallHealthy

primary ophthalmic solutions Company Information

Share PRIMARY OPHTHALMIC SOLUTIONS

Company Number

10654683

Shareholders

-

Group Structure

View All

Industry

Other human health activities

 

Registered Address

95 high street, beckenham, BR3 1AG

Website

-

primary ophthalmic solutions Estimated Valuation

£1.3m

Pomanda estimates the enterprise value of PRIMARY OPHTHALMIC SOLUTIONS at £1.3m based on a Turnover of £2.5m and 0.53x industry multiple (adjusted for size and gross margin).

primary ophthalmic solutions Estimated Valuation

£658.3k

Pomanda estimates the enterprise value of PRIMARY OPHTHALMIC SOLUTIONS at £658.3k based on an EBITDA of £161.5k and a 4.08x industry multiple (adjusted for size and gross margin).

primary ophthalmic solutions Estimated Valuation

£608.2k

Pomanda estimates the enterprise value of PRIMARY OPHTHALMIC SOLUTIONS at £608.2k based on Net Assets of £258.9k and 2.35x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Primary Ophthalmic Solutions Overview

Primary Ophthalmic Solutions is a live company located in beckenham, BR3 1AG with a Companies House number of 10654683. It operates in the other human health activities sector, SIC Code 86900. Founded in March 2017, it's largest shareholder is unknown. Primary Ophthalmic Solutions is a young, small sized company, Pomanda has estimated its turnover at £2.5m with healthy growth in recent years.

View Sample
View Sample
View Sample

Primary Ophthalmic Solutions Health Check

Pomanda's financial health check has awarded Primary Ophthalmic Solutions a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

3 Weak

size

Size

annual sales of £2.5m, make it larger than the average company (£682.6k)

£2.5m - Primary Ophthalmic Solutions

£682.6k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (8.1%)

11% - Primary Ophthalmic Solutions

8.1% - Industry AVG

production

Production

with a gross margin of 39.1%, this company has a comparable cost of product (39.1%)

39.1% - Primary Ophthalmic Solutions

39.1% - Industry AVG

profitability

Profitability

an operating margin of 6.4% make it as profitable than the average company (5.4%)

6.4% - Primary Ophthalmic Solutions

5.4% - Industry AVG

employees

Employees

with 3 employees, this is below the industry average (17)

3 - Primary Ophthalmic Solutions

17 - Industry AVG

paystructure

Pay Structure

on an average salary of £27.5k, the company has an equivalent pay structure (£27.5k)

£27.5k - Primary Ophthalmic Solutions

£27.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £823.9k, this is more efficient (£49.5k)

£823.9k - Primary Ophthalmic Solutions

£49.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 11 days, this is earlier than average (21 days)

11 days - Primary Ophthalmic Solutions

21 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 182 days, this is slower than average (16 days)

182 days - Primary Ophthalmic Solutions

16 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Primary Ophthalmic Solutions

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 46 weeks, this is less cash available to meet short term requirements (108 weeks)

46 weeks - Primary Ophthalmic Solutions

108 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 75.5%, this is a higher level of debt than the average (25.2%)

75.5% - Primary Ophthalmic Solutions

25.2% - Industry AVG

PRIMARY OPHTHALMIC SOLUTIONS financials

EXPORTms excel logo

Primary Ophthalmic Solutions's latest turnover from June 2024 is estimated at £2.5 million and the company has net assets of £258.9 thousand. According to their latest financial statements, Primary Ophthalmic Solutions has 3 employees and maintains cash reserves of £707.9 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Mar 2018
Turnover2,471,7962,030,5851,700,8471,802,6301,055,437823,415667,979
Other Income Or Grants
Cost Of Sales1,506,5671,244,0551,064,5261,194,845673,188529,728420,653
Gross Profit965,229786,531636,321607,785382,249293,687247,326
Admin Expenses807,126720,096638,024599,073363,412242,697232,783
Operating Profit158,10366,435-1,7038,71218,83750,99014,543
Interest Payable
Interest Receivable18,8162,751632
Pre-Tax Profit176,91969,185-1,0718,71218,83750,99014,543
Tax-44,230-17,296-1,655-3,579-9,688-2,763
Profit After Tax132,68951,889-1,0717,05715,25841,30211,780
Dividends Paid
Retained Profit132,68951,889-1,0717,05715,25841,30211,780
Employee Costs82,56878,22024,58247,40923,14045,615386,930
Number Of Employees33121218
EBITDA*161,47169,383-1,7038,71218,83750,99014,543

* Earnings Before Interest, Tax, Depreciation and Amortisation

Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Mar 2018
Tangible Assets10,1058,8438,56911,42515,23315,9702,910
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets10,1058,8438,56911,42515,23315,9702,910
Stock & work in progress
Trade Debtors75,769145,158157,374175,051106,24194,43148,045
Group Debtors
Misc Debtors263,569530,765180,001177,448143,688
Cash707,8878,912101,119
misc current assets64,29729,147
total current assets1,047,225684,835438,494352,499249,929158,72877,192
total assets1,057,330693,678447,063363,924265,162174,69880,102
Bank overdraft
Bank loan
Trade Creditors 752,843546,743367,592275,174181,603118,31643,419
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities45,58320,7205,145
total current liabilities798,426567,463372,737275,174181,603118,31643,419
loans
hp & lease commitments
Accruals and Deferred Income13,35315,2193,30024,903
other liabilities
provisions
total long term liabilities13,35315,2193,30024,903
total liabilities798,426567,463372,737288,527196,822121,61668,322
net assets258,904126,21574,32675,39768,34053,08211,780
total shareholders funds258,904126,21574,32675,39768,34053,08211,780
Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Mar 2018
Operating Activities
Operating Profit158,10366,435-1,7038,71218,83750,99014,543
Depreciation3,3682,948
Amortisation
Tax-44,230-17,296-1,655-3,579-9,688-2,763
Stock
Debtors-336,585338,548-15,124102,570155,49846,38648,045
Creditors206,100179,15192,41893,57163,28774,89743,419
Accruals and Deferred Income24,86315,575-8,208-1,86611,919-21,60324,903
Deferred Taxes & Provisions
Cash flow from operations684,789-91,73597,631-3,808-65,03448,21032,057
Investing Activities
capital expenditure-4,630-3,2222,8563,808737-13,060-2,910
Change in Investments
cash flow from investments-4,630-3,2222,8563,808737-13,060-2,910
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
interest18,8162,751632
cash flow from financing18,8162,751632
cash and cash equivalents
cash698,975-92,207101,119
overdraft
change in cash698,975-92,207101,119

primary ophthalmic solutions Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for primary ophthalmic solutions. Get real-time insights into primary ophthalmic solutions's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Primary Ophthalmic Solutions Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for primary ophthalmic solutions by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in BR3 area or any other competitors across 12 key performance metrics.

primary ophthalmic solutions Ownership

PRIMARY OPHTHALMIC SOLUTIONS group structure

Primary Ophthalmic Solutions has no subsidiary companies.

Ultimate parent company

PRIMARY OPHTHALMIC SOLUTIONS

10654683

PRIMARY OPHTHALMIC SOLUTIONS Shareholders

--

primary ophthalmic solutions directors

Primary Ophthalmic Solutions currently has 4 directors. The longest serving directors include Mr Priteshkumar Patel (Mar 2017) and Mrs Uma-Devi Patel (Mar 2017).

officercountryagestartendrole
Mr Priteshkumar Patel39 years Mar 2017- Director
Mrs Uma-Devi PatelUnited Kingdom49 years Mar 2017- Director
Mr Ketan JadejaEngland41 years May 2022- Director
Mr Matthew CarterEngland40 years May 2024- Director

P&L

June 2024

turnover

2.5m

+22%

operating profit

158.1k

0%

gross margin

39.1%

+0.81%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2024

net assets

258.9k

+1.05%

total assets

1.1m

+0.52%

cash

707.9k

+78.43%

net assets

Total assets minus all liabilities

primary ophthalmic solutions company details

company number

10654683

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86900 - Other human health activities

incorporation date

March 2017

age

8

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

June 2024

previous names

N/A

accountant

-

auditor

-

address

95 high street, beckenham, BR3 1AG

Bank

-

Legal Advisor

-

primary ophthalmic solutions Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to primary ophthalmic solutions.

primary ophthalmic solutions Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for PRIMARY OPHTHALMIC SOLUTIONS. This can take several minutes, an email will notify you when this has completed.

primary ophthalmic solutions Companies House Filings - See Documents

datedescriptionview/download